Latest AL-S Pharma News & Updates

See the latest news and media coverage for AL-S Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AL-S Pharma

Biotechnology company developing ALS therapies

al-spharma.com
Founded year
2016
Company type
Private company
Number of employees
10–50
Industry
Pharmaceuticals

Last updated

Latest news about AL-S Pharma

In short: AL-S Pharma presented positive Phase 2 data for its ALS candidate AP-101 and announced preparations for a confirmatory Phase 3 trial.

Company announcements

AL-S Pharma

AL-S Pharma discusses AP-101 Phase 2 data

Chief Medical Officer Angela Genge highlights survival improvements and biomarker reductions in ALS patients. Next steps follow Phase 2 success.

AL-S Pharma

AL-S Pharma shares Phase 2 data for AP-101 at AD/PD

Dr. Angela Genge presents on March 19, 2026, in Copenhagen. AP-101 targets misfolded SOD1 in ALS patients.

Unlock all announcements with a

Media coverage

Yahoo

AD/PD 2026: AL-S Pharma’s AP‑101 data backs approach to target misfolded SOD1 in ALS

On 19 March, at the AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and ...

Unlock all articles with a

Never miss news about AL-S Pharma

Track AL-S Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AL-S Pharma competitors & trending companies

Browse news for competitors to AL-S Pharma and other trending companies.